# O-GlcNAcylation Induced HMGB1 Signalling

> **NCT07702253** · — · ACTIVE_NOT_RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 120 (estimated)

## Conditions studied

- Esophageal Squamous Cell Carcinoma (ESCC)

## Interventions

- **OTHER:** specimen collection

## Key facts

- **NCT ID:** NCT07702253
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2036-03-31
- **Final completion:** 2037-03-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07702253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07702253, "O-GlcNAcylation Induced HMGB1 Signalling". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07702253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*